Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7380
    -0.0006 (-0.09%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    94,693.44
    -814.84 (-0.85%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6842
    -0.0001 (-0.01%)
     

5 plays on big-name retail stocks

5 plays on big-name retail stocks

Shares of recently battered retailer Gap (NYSE: GPS) seem cheap enough to buy, despite Thursday's mixed quarterly earnings report, some CNBC "Fast Money" traders said.

The company met Wall Street's profit expectations of 56 cents per share, but its $3.66 billion in sales fell slightly short of forecasts. Even after the stock has dropped more than 8 percent this year, it could climb, said trader Karen Finerman.

"The stock's not expensive here. I don't think you're paying a lot for the turnaround," she said.

Markets showed little reaction to Gap's results, as shares fell about 0.2 percent in extended trading Thursday. At $38 per share, "a lot of bad news" is priced in, said trader Tim Seymour.

ADVERTISEMENT

Read More Look who's winning the turnaround game

Investors should use caution on Gap, but it may hold some upside moving forward, said trader Guy Adami.

"You're not going to get crushed here, being long in Gap at $38," he said.

Gap's discount brand, Old Navy, had 3 percent comparable-store-sales growth in the quarter-a bright spot the retailer outlined on Thursday. But in the discount space, trader Brian Kelly looked to TJX Companies (NYSE: TJX).

Read More The latest retailer to jump on the discount bandwagon

Shares of the retailer-which owns TJ Maxx and Ross brands-have climbed 19 percent in the last year.

CVS Health

The second-largest U.S. drugstore operator, CVS (NYSE: CVS), will buy pharmacy services provider Omnicare (NYSE: OCR) for $10.1 billion, it announced Thursday. The move helps CVS expand into the senior patient population.

CVS shares rose more than 2 percent Thursday.

"I think they can do a great job with this acquisition," said Finerman, whose firm Metropolitan Capital Advisors owns CVS stock.

- Reuters contributed to this report.

Disclosures:

Tim Seymour

Tim Seymour is long AAPL, T, BAC, C, DIS, F, GE, GM, GOOGL, INTC, JCP and SUNE. Tim's firm is long BABA, BIDU, CHL, MCD, NKE, NOK, SBUX, SINA and YHOO.

BRIAN KELLY

Brian Kelly is long DXGE, BTC=, BBRY and U.S. dollar. He is short Australian dollar, Canadian dollar, euro, yen, yuan, and WTI crude oil.

Karen Finerman

Karen is long BABA, BAC, C, FINL, FL, GILD, GOOG, GOOGL, JPM, M, KORS and SEDG. She is short SPY. Her firm is long ANTM, AAPL, BAC, C, CVS, DIS, FBT, FINL, FL, GOOG, GOOGL, GPS, IBB, JPM, M, MU, PLCE, KORS, SEDG, SUNE, URI, XBI, GPS puts and S&P puts. Her firm is short IWM, SPY and MDY. Karen Finerman is on the board of GrafTech International.

Guy Adami

Guy Adami is long CELG, EXAS and INTC. Guy Adami's wife, Linda Snow, works at Merck.




More From CNBC